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Background: Psychiatric disorders are common mental disorders without a pathological biomarker. Classic
genetic studies found that an extra X chromosome frequently causes psychiatric symptoms in patients with
either Klinefelter syndrome (XXY) or Triple X syndrome (XXX). Over-dosage of some X-linked escapee genes
was suggested to cause psychiatric disorders. However, relevance of these rare genetic diseases to the pathogen-
esis of psychiatric disorders in the general population of psychiatric patients is unknown.
Methods: XIST and several X-linked genes were studied in 36 lymphoblastoid cell lines from healthy females and
60 lymphoblastoid cell lines from female patientswith either bipolar disorder or recurrentmajor depression.XIST
and KDM5C expressionwas also quantiﬁed in 48 RNA samples frompostmortemhuman brains of healthy female
controls and female psychiatric patients.
Findings:We found that the XIST gene, a master in control of X chromosome inactivation (XCI), is signiﬁcantly
over-expressed (p = 1 × 10−7, corrected after multiple comparisons) in the lymphoblastoid cells of female
patients with either bipolar disorder ormajor depression. The X-linked escapee gene KDM5C also displays signif-
icant up-regulation (p= 5.3 × 10−7, corrected after multiple comparisons) in the patients' cells. Expression of
XIST and KDM5C is highly correlated (Pearson's coefﬁcient, r = 0.78, p = 1.3 × 10−13). Studies on human
postmortem brains supported over-expression of the XIST gene in female psychiatric patients.
Interpretations:Wepropose that over-expression of XISTmay cause or result from subtle alteration of XCI, which
up-regulates the expression of some X-linked escapee genes including KDM5C. Over-expression of X-linked
genes could be a common mechanism for the development of psychiatric disorders between patients with
those rare genetic diseases and the general population of female psychiatric patients with XIST
over-expression. Our studies suggest that XIST and KDM5C expression could be used as a biological marker for
diagnosis of psychiatric disorders in a signiﬁcantly large subset of female patients.
Research in context: Due to lack of biological markers, diagnosis and treatment of psychiatric disorders are subjec-
tive. There is utmost urgency to identify biomarkers for clinics, research, and drug development.We found that XIST
and KDM5C gene expression may be used as a biological marker for diagnosis of major affective disorders in a sig-
niﬁcantly large subset of female patients from the general population. Our studies show that over-expression ofXIST
and someX-linked escapee genesmay be a commonmechanism for development of psychiatric disorders between
the patients with rare genetic diseases (XXY or XXX) and the general population of female psychiatric patients.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The presence of an extra X chromosome causes Klinefelter syndrome
(XXY) and Triple X syndrome (XXX). In the general population, the
frequency of Klinefelter syndrome in men or Triple X syndrome in
women is about 0.1%. However, there is a 4 to 5 fold increase of the
prevalence of Klinefelter syndrome or Triple X syndrome in inpatients
with psychiatric disorders (DeLisi et al., 1994). The increased prevalence
in the inpatient psychiatric populations may underestimate they, University of California, San
. This is an open access article underfrequency of psychiatric symptoms in subjects who carry these rare
genetic syndromes but are not admitted as psychiatric patients. In the
non-psychiatric patients with Klinefelter syndrome, psychosis was
reported in up to 50–65% of patients in some studies in addition to
other psychiatric symptoms (DeLisi et al., 1994). Otter et al. (2010)
summarized psychological impairments of women with Triple X
syndrome. Mood disorders and psychosocial impairments in Triple X
syndrome ranged from 25% to 70% in different studies (Otter et al.,
2010; Bender et al., 2001). Large variations in the frequency of psychiat-
ric symptoms in different studies can partially be attributed to patients'
ages. About 30% to 50% of children with either XXY or XXX display
attention-deﬁcit hyperactivity disorder (ADHD) symptoms (Tartaglia
et al., 2012). Supernumerary X chromosomes cause over-expression ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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over-dosage of X-linked escapee genesmay contribute to the pathogen-
esis of psychiatric phenotypes in these rare patients carrying aneuploid
X chromosomes (DeLisi et al., 2005). Whether over-dosage of X-linked
genes may be present in the general population of psychiatric patients
with a normal karyotype remains unknown.
X chromosome inactivation (XCI) is a fundamental biological
process to prevent over-expression of X-linked genes in females to
ensure the same dosage between men and women (Lee and Bartolomei,
2013). In mice, Xist is the master gene in the initiation of XCI (Kay et al.,
1993; Penny et al., 1996; Plath et al., 2002). Tsix, Ftx, and Jpx genes,
localized in X chromosome inactivation center (XIC), encode non-
coding RNAs to regulate expression of Xist (Lee et al., 1999; Chureau
et al., 2011; Tian et al., 2010). Most genes on the inactive X chromosome
are silenced in somatic cells, but about 10 to 15% of X-linked genes escape
XCI (Johnston et al., 2008). XCI is stable and well preserved in human
lymphoblastoid cells (Johnston et al., 2008; Zhang et al., 2013) that
provide convenient resources to study XCI effects in human diseases
(Amir et al., 2000).
We came across XCI from a very different research journey. Our pre-
vious studies found that inhibition of protein translationmay contribute
to pathogenesis of major psychiatric disorders in a rare Scottish family
(Ji et al., 2014). Given that excessive protein translation was suggested
in fragile X syndrome and autism, we speculated that abnormal protein
translation might contribute to a wide range of mental disorders not
only in rare families, but also in the general population. In this study,
we analyzed protein translation activity in psychiatric patients'
lymphoblastoid cells. The lymphoblastoid cells from patients exhibited
a signiﬁcantly larger variation in protein translation activity than that
from the healthy controls. Surprisingly, all variation in protein transla-
tion activity came from the female patients. These ﬁndings prompted
us to investigate functions of the X chromosome in the female patients'
lymphoblastoid cells.We examined expression of XIST and several other
X-linked genes in the lymphoblastoid cells of patients with different
psychiatric disorders. XIST expression was also investigated in the post-
mortem brains of patients with bipolar disorder, major depression, and
schizophrenia.2. Materials and methods
2.1. Lymphoblastoid cell culture
Studies on human lymphoblastoid cells were conducted under a Uni-
versity of California San Diego IRB-approved protocol. All lymphoblastoid
cell lines were kindly provided by Dr. John R. Kelsoe at UCSD. The cells
were in their early passages (b20 passages) (Oh et al., 2013). Demo-
graphic information of the subjects is summarized in Table 1. All female
patients except one have a family history with one or more relatives
suffering from psychiatric disorders. There is no signiﬁcant difference in
age between healthy controls and patients when blood was taken toTable 1
Lymphoblastoid cell lines from patients and controls.
Gender Agea
(mean +/− SD)
European Caucasians
CTRL Female (13) 39.9 +/− 13.7 Y
Male (13) 44.6 +/− 11 Y
BP Female (13) 41.7 +/− 13 Y
Male (14) 44.7 +/− 10.5 Y
MDR Female (10) 44.3 +/− 11.5 Y
CTRL (mixed) Female (23) 35.8 +/− 11.6 Mixed
BP (mixed) Female (23) 42.4 +/− 15.6 Mixed
MDR (mixed) Female (14) 41.9 +/− 11.3 Mixed
a At age when blood was taken.generate lymphoblastoid cell lines by transformation with Epstein–Barr
virus (EBV). Samples with mixed ethnic backgrounds were collections
of subjects with various and mixed ethnicity. Lymphoblastoid cell lines
were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium
containing 10% fetal bovine serum (Life Technologies, CA) with penicillin
and streptomycin (Life Technologies, CA) at 37 °C in a humidiﬁed atmo-
sphere of 5% CO2. Fresh medium was added or cells were sub-cultured
every 4 days. Cells were harvested for analysis 24 h after addition of
fresh medium. The group of lymphoblastoid cell lines from the healthy
European Caucasian female controls was co-cultured with the cell lines
from each of the other groups. It served as the common control that
was used to calibrate gene expression across all samples (Supplemental
method I).
2.2. Quantitative real-time RT-PCR
Total RNA was extracted from lymphoblastoid cells with TRIzol
reagent (Invitrogen, Carlsbad, CA). Primers were selected to amplify
exonswithout alternative splicing in order to quantify all RNA isoforms.
All PCR primers were ﬁrst conﬁrmed to speciﬁcally amplify the target
cDNA genes without background before being used for qRT-PCR. cDNA
was synthesized from 5 μg of total RNA using Superscript III First-
Strand Synthesis System (Invitrogen, Carlsbad, CA) with random
hexamers. SYBR Green real-time PCR was used to quantify relative
expression of all genes with a comparative Ct method. The standard
curve of PCR ampliﬁcation was examined. All ampliﬁcations had
R2 N 0.99. Ampliﬁcation efﬁciency for each pair of primers was deter-
mined using known molecular concentration of template DNA. Each
sample had 4 ampliﬁcation replica wells. After ampliﬁcation, Ct was
set in the exponential ampliﬁcation phase of the curve as recommended
by the manufacturer's protocol (Bio-Rad CFX384). Variation of cycles
between ampliﬁcation replica wells was smaller than 0.5 cycles.
β-Actin was used as a reference control for normalization. The primers
used in real-time qRT-PCR are in Supplemental method II.
2.3. Western blot
Lymphoblastoid cells were collected by centrifugation and sonicated
in passive lysis buffer (Promega,WI)with 1× protease inhibitor cocktail
(P8340, Sigma). Protein concentration was measured using the Brad-
ford (Abs 595 nm)methodwith Coomassie Plus Protein Assay (Thermo
Scientiﬁc, IL). 50 μg of proteinswere loaded forWestern blot analysis (Ji
et al., 2014). Rabbit anti-KDM5C (cat. 39230, dilution at 1:7,500, Active
Motif, Carlsbad) andmouse anti-β-actin (sc-47778, dilution at 1:10,000,
Santa Cruz) were used as primary antibodies. Horseradish peroxidase
(HRP)-conjugated anti-mouse IgG (dilution at 1:10,000, Cell signaling,
MA) or HRP-conjugated anti-rabbit IgG (dilution at 1:10,000, Santa
Cruz, CA) were used as secondary antibodies. Pierce ECL Western blot
substrate (Pierce, IL) was used for chemiluminescence visualization.
Quantiﬁcation of Western blot bands was conducted using Image J.Family history Mania Psychosis Depression Severity
Y Y Y Severe
Y (13), N (1) Y Y Severe
Y (9), N (1) Y Moderate
Y Y Y
Y Y Moderate
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Lymphoblastoid cell lines from 4 female controls and 4 female
patients with high XIST expression were selected for examination of
H3K27me3 on the inactive X chromosome. 1.5×107 cellswere harvested
from each cell line. Cells were ﬁxed, and chromatin was sheared.
Chromatin immunoprecipitation was performed using ChIP-IT High
Sensitivity Kit (Active Motif) according to its manual. Mouse monoclonal
antibody against H3K27me3 (cat. 61017) was purchased from Active
Motif. 6 pairs of primers were designed to amplify immunoprecipitated
genomic DNA (each about 150 bp) around the transcription start
site of the XIST gene. 2 pairs of primers were selected to amplify
immunoprecipitated genomic DNA around the transcription start site of
the KDM5C gene. Ampliﬁcation of immunoprecipitated β-actin genomic
DNA was used as a reference control to quantify enrichment of
H3K27me3 at the promoters of XIST and KDM5C genes. All primers
were ﬁrst tested for speciﬁc ampliﬁcation of their target DNA without
non-speciﬁc background before being used for ChIP-QPCR. SYBR
Green real-time PCR was used to quantify the amount of DNA
immunoprecipitated by anti-H3K27me3 with a comparative Ctmethod.
The primers used in ChIP-QPCR are in Supplemental method III.
2.5. RNA from postmortem human brains
We received 48 RNA samples from cingulate cortex of female
subjects from both Array Collection and Depression Collection (Stanley
Medical Research Institute, SMRI). Expression of XIST and KDM5C was
quantiﬁed blind to diagnosis. After submitting the quantiﬁcation data
to SMRI, we received the diagnostic code for each subject. All subjects
are European female Caucasians. Detailed information about the pa-
tients and controls can be found online (http://www2.stanleyresearch.
org/brain-research/).
2.6. Outcomes
Our primary objective was to ﬁnd whether expression of X-linked
genes including XIST is altered in the general population of female pa-
tients with psychiatric disorders. Our secondary objective was to ﬁnd
whether alteration of these genes' expression in lymphoblastoid cells
may potentially serve as a biological marker for the diagnosis of psychi-
atric disorders in a subset of female patients.
2.7. Statistical analyses
All data were ﬁrst tested for normal distribution using the Kolmogo-
rov–Smirnov test. F-tests were used to assess the equality of variances
between two samples. Student's t-test was used for statistical analyses
between two samples. Correction of multiple comparisons was con-
ducted by using false discovery rate (FDR) (http://www.sdmproject.
com/utilities/?show=FDR).
2.8. Role of the funding sources
Not applicable.
3. Results
To measure protein translation activity, lymphoblastoid cells were
ﬁrst serum-starved for 8 h to synchronize cell growth before re-
stimulated with a normal concentration of serum. Protein translation
activity was measured 8 h after serum re-stimulation using the SUnSET
(surface sensing of translation) method (Ji et al., 2014; Schmidt et al.,
2009). After analyzing 26 healthy controls and 28 bipolar patients
with severe mania and psychosis, we found a signiﬁcantly larger varia-
tion of protein translation activity in the patients' lymphoblastoid cell
lines (Fig. S1A and B). The different SUnSET intensities between celllines came from differential activities of protein synthesis rather than
differential uptake of puromycin (Fig. S1C). A high correlation of SUnSET
intensities between the synchronized cells and asynchronized prolifer-
ating cells was observed (data not shown). No correlation was found
between individuals' age and protein translation activity (Fig. S1D).
When the SUnSET datawere sub-grouped according to gender, however,
we found that all variations in protein translation activity came from the
female patients (Fig. S1E).
Restriction of abnormal protein translation activity to the female
patients' lymphoblastoid cells prompted us to investigate potential
dysregulation of X chromosome functions. We examined XCI in female
lymphoblastoid cells by quantifying expression of XIST, themaster gene
for XCI (Brown et al., 1992), and other noncoding RNA genes that are
involved in the regulation of XIST expression such as TSIX (Migeon
et al., 2002), FTX (Chureau et al., 2002), and JPX (Chureau et al., 2002).
We found that expression of XIST is signiﬁcantly higher (p= 0.001) in
the female patients than in the female controls (Fig. 1A). Contrary to
high XIST expression, TSIX expression is signiﬁcantly lower (p b 0.01)
in the patients' cells (Fig. 1B). We also observed a trend of high expres-
sion of FTX (p b 0.1) in the patients (Fig. 1C), but no differencewas found
in JPX expression (Fig. 1D). Altered expression of XIST and its negative
(TSIX) and positive (FTX) regulator genes within XIC indicates a poten-
tial alteration in XCI in the lymphoblastoid cells of the female patients.
To investigate whether other X-linked genes beyond XIC are affect-
ed, we randomly selected a few genes that are either completely
inactivated by or escapees from XCI. PGK1, G6PD and HPRT1 genes are
known to be inactivated by XCI, and KDM5C, KDM6A and RPS4X genes
are the well-established escapees from XCI in human lymphoblastoid
cells (Johnston et al., 2008). We found that expression of KDM5C is
signiﬁcantly higher (p b 0.05) in the female patients than in the female
controls (Fig. 1E). A trend of high expression (p b 0.1) of KDM6A
(Fig. 1F), PGK1 and G6PD genes (Fig. S2A and B) was observed in the
patients' cells before correction of multiple comparisons. No difference
was found in expression of either HPRT1 or RPS4X gene between the
patients and the controls (Fig. S2C and D). Expression of all these
genes was quantiﬁed with β-actin as the reference control. Using
GAPDH as a different reference control, we conﬁrmed over-expression
of XIST in the patients' cells (Fig. S2E). Since GAPDH expression is likely
more sensitive to cell culture conditions, we continued to use β-actin
expression as the reference control for all subsequent studies.
Altered expression of XIST, TSIX, KDM5C and KDM6A genes in
patients' lymphoblastoid cells is unlikely caused by any medication
history of the patients because prior treatment of lymphoblastoid cells
with both antipsychotics clozapine (CLZ) and mood stabilizer valproic
acid (VPA) has no effect on expression of any of these genes (Fig. S3A,
B, C, D). Additionally, expression of KDM5C and KDM6A genes was not
different in the lymphoblastoid cells of male patients from the healthy
male controls (Fig. S4), supporting that patients' medication history
has no effect on expression of X-linked genes in their lymphoblastoid
cells. Neither XIST nor KDM5C expression is affected by age (Fig. S5A,
B). There is no correlation between XIST expression and protein transla-
tion activity (SUnSET) (Fig. S5C). A weak correlation between KDM5C
expression and SUnSET intensitywas observed, but statistically insignif-
icant (Fig. S5D). It is possible that other autosomal genes that vary
between individuals may also be involved in the regulation of protein
translation activity.
To investigate whether abnormal expression of XIST and other
X-linked genes also presents in females with a different psychiatric
disorder, we examined the expression of XIST, TSIX, KDM5C, KDM6A,
PGK1, and G6PD genes in the lymphoblastoid cells of female patients
with recurrent major depression. These genes were chosen because
they displayed signiﬁcant or trend increases of expression in the female
bipolar patients with mania and psychosis. Expression of XIST was
signiﬁcantly higher (p b 0.01) in the female patients with recurrent
major depression than in the female healthy controls (Fig. 2A). Down-
regulation of TSIX expression was, however, not statistically signiﬁcant
Fig. 1. Abnormal expression of XIST and its regulator genes involved in XCI. Each dot represents a human subject. Black = healthy European Caucasian female controls (CTRL); red =
European Caucasian female bipolar (BP) patients with mania and psychosis. Multiple comparisons of Student's t-tests were corrected with FDR. (A) A signiﬁcantly higher level of XIST
RNA expressionwas observed in the patients than in the controls (t(23)=−4.23, p=0.001). (B) Consistent with its negative role, therewas a signiﬁcantly lower level of TSIX expression
in the patients (t(23)= 3.43, p b 0.01). (C) Consistent with its positive role, a trend of high expression of FTXwas detected in the patients (t(23)=−2.00, p b 0.1). (D) No differencewas
observed in JPX expression between the controls and patients (t(23) =−0.24, ns). (E) A signiﬁcantly higher level of KDM5C expression (t(23) =−2.89, p b 0.05) was observed in the
patients. (F) Therewas a trend of high expression inKDM6A (t(23)=−2.00, p b 0.1) in the patients before correction ofmultiple comparisons. (***p b 0.001, **p b 0.01, *p b 0.05, # p b 0.1).
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Expression of KDM5C was also signiﬁcantly higher (p b 0.001) in the
patients with recurrent major depression (Fig. 2C). Consistent with a
trend of high KDM6A expression in the female bipolar patients, we
observed a signiﬁcantly higher expression of KDM6A (p b 0.05) in the
lymphoblastoid cells of female patients with recurrent major depres-
sion (Fig. 2D). No difference was found in either PGK1 or G6PD expres-
sion between the female patients and the healthy female controls
(Fig. S6A and B). To enlarge the sample size of the healthy female
controls, we analyzed expression of XIST, KDM5C and KDM6A genes in
a group of healthy females who have various ethnic genetic
backgrounds (“mixed”). No difference was observed in either XIST or
KDM5C expression between the European Caucasian female controls
and the female controls with various ethnic genetic backgrounds
(Fig. 2E and F). A slightly higher level of KDM6A expression was
observed in the controls with various ethnic backgrounds (Fig. S6C).
Given that KDM6A expression varies between different cell cultures of
the control samples (Fig. 1F vs Fig. 2D), it is not surprising that its
expression was also affected by different ethnic backgrounds. We
concluded that ethnic background has little effect on XIST and KDM5C
expression. To enlarge the sample sizes of the psychiatric patients, weincluded more patients who have either bipolar disorder (mania and
psychosis) or recurrent major depression with various ethnic back-
grounds. Signiﬁcant difference in either XIST or KDM5C expression was
observed between the control group and each of the two patient groups
(Fig. 3A and B). Since the same healthy European female Caucasians
were used as a calibrator and control for analyses of all other control
and patient groups, gene expression in each subject was therefore
normalized against the group mean of the healthy European female
Caucasians whose cells were co-cultured for quantiﬁcation. There was
a signiﬁcantly larger variation of XIST expression between the combined
control and the combined groups of either bipolar disorder (p =
8 × 10−5, F-test) or major depression (p = 1 × 10−10, F-test)
(Fig. 3C). When both bipolar and major depression were combined
(BP + MDR), a signiﬁcantly larger variation was observed (p =
1 × 10−8, F-test). Additionally, signiﬁcant increase of XIST expression
was also detected in bipolar (p = 1 × 10−7), major depression (p =
0.004), and the combined (BP+MDR) group (p=1× 10−7). Similarly,
a larger variation of KDM5C expressionwas found in bipolar (p=0.002,
F-test), major depression (p = 0.004, F-test), and the combined
(BP + MDR) group (p = 0.001, F-test) (Fig. 3D). Signiﬁcant increase
of KDM5C expression was also observed in bipolar disorder (p =
Fig. 2.Over-expression ofXIST,KDM5C, andKDM6A in patientswith recurrentmajor depression. Each dot represents a human subject. Black=healthyEuropeanCaucasian female controls
(CTRL); red= European Caucasian female patients with recurrentmajor depression (MDR); gray= healthy female controls with various ethnic genetic backgrounds (mixed CTRL). Mul-
tiple comparisons of Student's t-testswere correctedwith FDR. (A) A signiﬁcantly larger variationwas observed inXIST expression in the patients group (p=0.001, F-test). Therewas also
a signiﬁcantly higher level of XIST expression (t(11)=−4.16, p b 0.01, unequal variances) in the patients than in the controls. (B) Down-regulation of TSIX expressionwas not statistically
signiﬁcant (t(21) = 1.35, ns). Larger variation was observed in either KDM5C (p= 0.027, F-test) or KDM6A (p= 5.9 × 10−5, F-test) gene expression in the patients. There was also sig-
niﬁcantly higher expressionofKDM5C (C)(t(13)=−4.45, p b 0.001, unequal variances) andKDM6A (D)(t(10)=−2.23, p=0.05, unequal variances) in the patients lymphoblastoid cells.
There is no difference in XIST (E) or KDM5C (F) expression between healthy European Caucasian female controls and healthy female controls with various ethnic genetic backgrounds.
(**p b 0.01, *p b 0.05).
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(BP +MDR) group (p= 5.3 × 10−7). A high correlation was observed
between XIST and KDM5C expression in all patients' cells (Pearson's
coefﬁcient, r= 0.78, p= 1.3 × 10−13) (Fig. 4A). We explored whether
a combination of XIST and KDM5C expression can be used as a potential
diagnostic marker to separate the patients from the controls. According
to calculation of reference range in clinical blood tests (William et al.,
2008), we calculated the reference ranges of XIST and KDM5C expres-
sion in the control females to deﬁne a “normal” distribution. The
upper limit of the reference range is deﬁned as 2 standard deviations
above the mean (dashed line, Fig. 4B). Out of 60 patients, 36 have XIST
and/or KDM5C expression above their reference ranges. Among them,
20 patients have both XIST and KDM5C expressions above their refer-
ence ranges. None of the 36 controls display abnormally high XIST
and/or KDM5C expression. Since it would be rare to have a control sam-
ple expressing both XIST and KDM5C above their reference ranges, we
propose that a combination of both XIST and KDM5C gene expressions
may serve as a reliable biological marker for diagnosis of bipolar disor-
der ormajor depression in a signiﬁcantly large subset of female patients.
We investigated whether cell passages may alter expression of XIST,
KDM5C, and KDM6A genes. Batches of cells from different cell passages
were collected and analyzed. The level of XIST expression is stable
between different cell passages (Fig. 5A). A high correlation of XISTexpression (Pearson's coefﬁcient, r = 0.88, p = 2.6 × 10−8) was
observed between the two different passages of individual cell lines. A
strong correlation in KDM5C expression was also observed between
the two different cell passages (Pearson's coefﬁcient, r = 0.6, p =
0.0028) (Fig. 5B). As expected, KDM6A expression appeared to be
more susceptible to variations between different cell cultures
(Fig. S6D). We did not detect an increase of X chromosome DNA copies
in the patients with high XIST expression, ruling out the presence of
patients with Triple X syndrome in our samples (Fig. S6E).
Consistent with over-expression of KDM5C mRNA in the patients'
cells, Western blot analyses found a signiﬁcantly higher level of
KDM5C protein (p b 0.01) in the patients' cells than in the controls'
cells (Fig. 5C and D). Epigenetic modiﬁcation of XIST and KDM5C genes
was also compared between the controls and the patients with
increased XIST and KDM5C expression. H3K27me3 is particularly
enriched on the inactive X chromosome because of Xist-dependent
recruitment of Polycomb repressor complex 2 (PRC2) that methylates
lysine 27 on histone 3 (Plath et al., 2003; Maenner et al., 2010; Zhao
et al., 2008). H3K27me3 was therefore examined around the promoters
of XIST and KDM5C genes using chromatin immunoprecipitation. XIST
(1) and XIST (3) sites have signiﬁcantly more abundant H3K27me3 in
the patients' lymphoblastoid cells than in the controls' lymphoblastoid
cells (Fig. 5E). KDM5C gene also displayed more abundant H3K27me3 at
Fig. 3. XIST and KDM5C over-expression in additional groups of patients with bipolar disorder or recurrent major depression. Each dot represents a human subject. Black = healthy
European Caucasian female controls (CTRL); red= patients with various ethnic backgrounds with either bipolar (mixed BP) or recurrent major depression (mixed MDR). Multiple com-
parisons of Student's t-tests were corrected with FDR. (A) Signiﬁcantly larger variations were observed in XIST expression in either bipolar (p=0.0038, F-test) or major depression (p=
0.0009, F-test). There was signiﬁcantly higher XIST expression (t(33)=−5.1, p b 0.00001, unequal variances) in the bipolar patients than in the controls. The mean of XIST expression of
major depression group was not signiﬁcantly different from the mean of the control group. (B) There is no difference in the variation of KDM5C expression between groups. Signiﬁcantly
higher expression of KDM5Cwas observed in both bipolar (t(34) =−2.71, p b 0.01) and major depression (t(24) =−2.84, p b 0.01) than in the controls. (C) Expression of XIST in all
individualswas normalized against themean of the European female controls thatwere co-cultured. After combining all data, signiﬁcantly larger variationwas observed inXIST expression
in bipolar (p= 8 × 10−5, F-test), major depression (p= 1 × 10−10, F-test), and their combined group (p= 1 × 10−8, F-test). In addition to the difference in variation, there was signif-
icantly higher XIST expression in bipolar (t(52) =−6.5, p=1 × 10−7, unequal variances), major depression (t(26) =−2.86, p= 0.004, unequal variances), and their combined group
(t(83)=−5.93, p=1 × 10−7, unequal variances). (D) Signiﬁcantly larger variation was found in KDM5C expression in bipolar (p=0.002, F-test), major depression (p=0.004, F-test),
and their combined group (p= 0.001, F-test). Signiﬁcantly higher KDM5C expression was observed in bipolar (t(58) =−4.9, p= 5.4 × 10−6, unequal variances), major depression
(t(34) =−3.3, p= 0.001, unequal variances), and their combined group (t(94) =−5.4, p= 5.3 × 10−7, unequal variances). (***p b 0.001, **p b 0.01).
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ferent lines of evidence support that aberrant regulation and expression
of XIST and KDM5C genes present in the lymphoblastoid cells of female
patients with psychiatric disorders.
With a limited number of available postmortem human brains from
female patients with major psychiatric disorders, we double-blindly
examined expression of XIST and KDM5C genes in the RNA of cingulate
cortex from both Array Collection and Depression Collection from Stan-
leyMedical Research Institute (SMRI). One ofmany confounding factors
in gene expression analysis is the potential cell heterogeneity of the
brain samples. If some brain tissues have signiﬁcantly more glial cells,
they may particularly distort quantiﬁcation of relative XIST expression,
presumably because XIST expression is more dependent on the number
of individual cells than the β-actin reference control. Therefore, we ﬁrst
conducted analysis of GFAP mRNA expression to evaluate relativeabundance of glial cells in all 48 female samples received from SMRI.
Two brain samples exhibited very high levels of GFAPmRNA expression
that was over 3 standard deviations above the group mean (Fig. 6A).
Both samples were determined as extreme outliers because they lie
outside of 3 interquartile ranges (IQR) above the upper quartile using
boxplot analysis. They were therefore excluded for further analysis.
Both XIST and KDM5C expression were quantiﬁed in the cingulate cor-
tex. One control sample displayed a very high level of XIST expression.
It is difﬁcult to know whether it is caused by other confounding factors
that associate with human postmortem brain tissues. Nevertheless, we
still detected a signiﬁcantly higher level of XIST expression in the bipolar
group (p b 0.05) and a trend of high level of XIST expression in themajor
depression group (p b 0.1) (Fig. 6B). Signiﬁcantly higher XIST expression
was also detected when bipolar disorder and major depression are
combined (p b 0.05) or when all patients are combined (p b 0.05). No
Fig. 4.Over-expression ofXIST andKDM5C as a potentially combinatorial biologicalmarker
for diagnosis ofmajor psychiatric disorders. Each dot represents a human subject. Black=
healthy female controls; red= female patients with either bipolar or recurrent major de-
pression. (A) Expression of XIST and KDM5C is highly correlated in all 60 patients'
lymphoblastoid cell lines (Pearson's coefﬁcient, r = 0.78, p = 1.3 × 10−13).
(B) Expression of XIST and KDM5C of the 36 controls' and 60 patients' lymphoblastoid
cell lines are plotted together. Reference ranges ofXIST and KDM5C expressionwere calcu-
lated from the 36 controls. M + 2SD: the dashed line corresponding to 2 standard devia-
tions above the means of XIST (shaded with light blue) and KDM5C (shaded with light
green) from the 36 controls. A signiﬁcantly large number of female patients randomly col-
lected from the general population displayed higher expression of either XIST and/or
KDM5C above their reference ranges.
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late cortex between the control group and each of the patient groups
(Fig. 6C). Neither a correlation was found between XIST and KDM5C
expression in the cingulate cortex of postmortem human brains
(Fig. 6D). In summary, the postmortem brain data supported that
over-expression of XIST occurs in both lymphoblastoid cells and the
postmortem brains of female patients with bipolar disorder or major
depression.
4. Discussion
Our studies suggest that over-expression of both XIST and KDM5C
genes may serve as a biological marker for diagnosis of bipolar disorder
with mania and psychosis or recurrent major depression in females. In
60 lymphoblastoid cell lines established from randomly collected
female patients from the general population, about 30% to 60% of the
patients can be diagnosed by these markers using different stringency.
Not all female patients displayed over-expression of XIST and/or
KDM5C genes, suggesting heterogeneity of genetic etiologies in the
general population of female patients. Most of the female patientsused in our studies have a family history ofmental disorders and display
severe psychiatric symptoms. Therefore, our studies may over-estimate
the prevalence of abnormal XIST and KDM5C expression in the general
population of female psychiatric patients without family history and/
or with milder psychiatric symptoms.
The levels of XIST and KDM5C expression are stable between different
passages of lymphoblastoid cells. Their expression is unaffected by
patients' ages when the blood was drawn for establishment of
lymphoblastoid cell lines. Consistent with our studies on humans,
mouse Xist expressionmaintains the same high level of expression across
development (Buzin et al., 1994) and between different adult tissues
(Kay et al., 1993;Ma and Strauss, 2005).We propose that XIST expression
could be a stable trait that associates with the state of X chromosomes in
female somatic cells since establishment of XCI. Given that psychiatric
symptoms mostly develop in late adolescence, it may be feasible to
measure XIST and KDM5C expression in the lymphocytes from girls at
childhood or early adolescence to predict the risk of developing major
psychiatric disorders in young adulthood. Such studies merit further
investigation in the future, as early diagnosis can greatly help early inter-
vention as demonstrated in autism (Rogers et al., 2014).
XIST is a unique gene. It encodes a 19 kb long noncoding RNA and
serves as the master gene in both initiation (Kay et al., 1993; Penny
et al., 1996; Plath et al., 2002) and maintenance (Yildirim et al., 2013)
of X chromosome inactivation (XCI). Mouse Tsix, Ftx, and Jpx genes,
localized in X chromosome inactivation center (XIC), have been demon-
strated to regulate expression of Xist during XCI initiation (Lee et al.,
1999; Chureau et al., 2011; Tian et al., 2010). In the lymphoblastoid
cell lines, signiﬁcant down-regulation of TSIX (a negative regulator of
XIST expression) and a trend of high level of FTX (a positive regulator
of XIST expression) were observed in the patients with mania and
psychosis. However, we failed to detect signiﬁcant differences in their
expression in the patients with recurrent major depression. It is unclear
what roles these negative and positive noncoding RNAs play in
regulation of XIST expression in the lymphoblastoid cells. In addition,
epigenetic modiﬁcations of XIST and KDM5C loci are also altered, which
accompany over-expression of both genes in patients' lymphoblastoid
cell lines. Taken together, all of these data support aberrant regulation
and expression of XIST and some other X-linked genes in the patients'
lymphoblastoid cells. We suggest that subtle XCI deﬁciency may occur
in the patients' lymphoblastoid cells to cause over-expression of
X-linked escapee genes KDM5C and KDM6A. Over-expression of XIST
may be a compensatory response to XCI deﬁciency. Such a subtle
deﬁciency appears to be insufﬁcient to cause over-expression of most
X-linked genes since we did not observe consistent up-regulation of
PGK1, G6PD and HPRT1 genes in patients' lymphoblastoid cell lines.
However, over-expression of XISTmay alter epigenetic state of inactive
X chromosome via recruiting excessive XIST-dependent protein
complexes. Therefore, we cannot rule out potential active roles of XIST
over-expression in regulation of XCI, although the exact mechanisms
remain to be investigated. There is a robust correlation between XIST
and KDM5C expression in patients' lymphoblastoid cell lines. However,
we did not observe such a correlation in the cingulate cortex of postmor-
tem brains. Given that X-linked escapee genes display tissue-speciﬁc
variation in degree of escape (Berletch et al., 2015; Sheardown et al.,
1996), the correlation between XIST and KDM5C expression may be
cell-speciﬁc. Additionally, other confounding factors such as tissue
heterogeneity in the postmortem brains may disrupt such a correlation
(if there is any). Due to lack of allele-speciﬁc polymorphisms of XIST
RNA in our samples, we do not know whether XIST over-expression
comes exclusively from the inactive X chromosome in patients'
lymphoblastoid cell lines. RNA ﬂuorescent in situ hybridization (FISH)
experiments on patients' lymphoblastoid cells may be conducted in the
future to clarify the localization of XIST over-expression.
X chromosome plays an important role in the development of
psychiatric disorders (Goldstein et al., 2013; Perrin et al., 2010; Crow,
2013; Ross et al., 2001, 2006). Over-dosage of X-linked escapee genes
Fig. 5. XIST and KDM5C expression across passages and alteration of epigenetic modiﬁcations in the patients. Each dot represents a human subject. Black = healthy European Caucasian
female controls (CTRL); red = European Caucasian female patients with recurrent major depression (MDR). XIST (A) and KDM5C (B) gene expression was examined in the ﬁrst batch of
lymphoblastoid cells (XIST-1 and KDM5C-1). After more than amonth of continuous cell culture, the same set of genes was examined again in the second batch of the same cell lines with
different cell passages (XIST-2 and KDM5C-2). A high correlation ofXIST (Pearson's coefﬁcient, r=0.88, p=2.6× 10−8) andKDM5C (Pearson's coefﬁcient, r=0.6, p=0.0028) expression
was observed between the two batches of cells with different passages. (C)Western blot analyses of KDM5C protein expression in the lymphoblastoid cells of female patients with recur-
rent major depression. A single band at 180 kD, the calculated size of human KDM5C protein, was detected. C: controls; D: recurrent major depression. β-actin was used as an internal
control for normalization. (D) Consistent with increased mRNA expression, signiﬁcantly higher KDM5C protein expression was found in the patients (t(22) = −2.85, p b 0.01).
(E) Lymphoblastoid cell lines from 4 female controls (black) and 4 female patients (red) with either recurrent major depression or mania and psychosis were selected for chromatin im-
munoprecipitation experiments. Six sites, separated by ~1 kb (except a 2 kb between 1 and 2) around the promoter of XIST gene, were examined by ChIP-QPCR. Multiple comparisons of
Student's t-testswere correctedwith FDR. SigniﬁcantlymoreH3K27me3was observed in the patients' lymphoblastoid cells at XIST (1) (t(6)=−3.83, p b 0.05) and XIST (3) (t(6)=−3.2,
p b 0.05). A trend of more H3K27me3 at XIST (4) (t(6) =−2.7, p b 0.1) was also observed. (F) Two sites around the promoter of KDM5C gene were also examined by CHIP-QPCR.
H3K27me3 is signiﬁcantly more enriched at KDM5C (1) (t(6) =−3.39, p b 0.05) in female patients' lymphoblastoid cells.
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development of psychiatric symptoms in both Klinefelter syndrome
(XXY) and Triple X syndrome (XXX) (DeLisi et al., 2005). Inlymphoblastoid cells from the female psychiatric patients, not all
studied X-linked escapee genes displayed concomitant up-regulation
with XISTover-expression. For example, escapee gene RPS4X has normal
Fig. 6.Over-expression of XIST in postmortembrains of female patients withmajor psychiatric disorders. All 48 female RNA samples frompostmortem human brainswere kindly provided
by Stanley Medical Research Institute. Expression of XIST and KDM5C was double-blindly quantiﬁed. Each dot represents a human subject. Gray = all subjects; black = healthy female
controls (CTRL); red= female patients with bipolar disorder (BP), recurrent major depression (MDR), and schizophrenia (SCZ). (A) To assess cell heterogeneity of the samples, GFAP ex-
pression was quantiﬁed to evaluate relative abundance of glial cells in the samples. 2 samples displayed high levels of GFAP expression above 3 interquartile ranges (IQR) above the upper
quartile using boxplot analysis. Therefore, both were determined as extreme outliers and excluded for further analyses. (B) There was one control sample with a very high level of XIST
expression that is qualiﬁed as an outlier. Due to small sample size, it was retained. There was signiﬁcantly higher XIST expression in bipolar disorder (t(24) =−2.07, p= 0.025), and
a trend of high XIST in major depression (t(20)=−1.35, p=0.096). Signiﬁcantly higher XIST expression was also detected when bipolar disorder andmajor depression were combined
orwhen all patientswere combined. (C) Therewas no signiﬁcant difference inKDM5C expression between the control group and any patient group. (D) Therewas no correlation between
XIST and KDM5C expression in the postmortem brains of the patients.
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more X-linked escapee genes is needed in the future. Nevertheless, it
is plausible that over-expression of XIST and some escapee genes may
be a commonmechanism underlying development of psychiatric disor-
ders between the rare patients with aneuploid X chromosomes and a
subset of the general population of female psychiatric patients with a
normal karyotype. Among these escapee genes, KDM5C is particularly
interesting since its haploinsufﬁciency causes mental retardation
(Ounap et al., 2012; Fieremans et al., 2015) or mood disorder (Jensen
et al., 2005) in females. Mutations of KDM5C generate much more
severe mental retardation in males (Jensen et al., 2005; Rujirabanjerdet al., 2010). It will be interesting to know whether KDM5C over-
expression may contribute to psychiatric symptoms in the female
patients. Our studies suggest that subtle alteration of XCI could be a
unique genetic risk factor for psychiatric disorders in women. It could
be argued that the risk factor is XIST over-expression rather than subtle
alteration of XCI. This alternative hypothesis, however, cannot readily
explain the high correlation between expression of XIST and the
X-linked escapee gene KDM5C in the patients. Why does over-
expression of XIST and KDM5C occur in both bipolar disorder and
major depression? One explanation is that psychiatric disorders are
not distinct individual diseases, but a spectrum of mental disorders.
918 B. Ji et al. / EBioMedicine 2 (2015) 909–918For example, somepatients display bothmania anddepression. Another
explanation is that there are othermodiﬁer genes on autosomes that in-
teract with environment to result in different clinical symptoms. In fact,
patients with either Klinefelter syndrome or Triple X syndrome display
a variety of psychiatric symptoms that can be classiﬁed as bipolar disor-
der, major depression, schizophrenia, and other psychiatric disorders
(DeLisi et al., 1994, 2005; Tartaglia et al., 2012). A thorough analysis to
compare expression of X-linked genes between the patients with Triple
X syndrome and female psychiatric patients with a normal karyotype
will help understand the role of over-dosage of X-linked genes in the
pathogenesis of psychiatric disorders. Reversing abnormal expression
of the X-linked genes in affected females may potentially be a new
strategy for future treatment of psychiatric disorders.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2015.06.012.
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